As of Apr 24
| -0.26 / -1.06%|
The 3 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 35.00 and a low estimate of 31.00. The median estimate represents a +32.23% increase from the last price of 24.20.
The current consensus among 3 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.